Found "Innovation": 72 results
Sort by
Last updated

Comprehensive assessment of co-benefits and maladaptation of solarisation in Thailand

Thailand’s increasing demand for coal and fossil fuel-based energy has substantial climate, environmental, and public health consequences. In response, the Ministry of Energy has ambitious plans to increase the share of renewable energy to over 50% by 2037. A high priority intervention included in this plan is photovoltaic systems or ‘solarisat

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings

Abstract Understanding the financial and health consequences if economic evaluation assumptions prove incorrect is essential for managing the risk associated with benefit package decisions, particularly in resource-constrained and overburdened healthcare systems. Yet these are also the settings t

Thailand's AMR Strategy: Insights from the 5th National Forum on AMR

Thailand's National Forum on Antimicrobial Resistance (AMR), held every two years, serves as a platform to share knowledge and reinforce the importance of AMR as a global public health threat. Yet AMR rarely commands public attention, compared to non-communicable diseases, despite being associated w

Can AI Really Help Us Prevent Diabetes and Hypertension in Thailand?

Non-communicable diseases (NCDs) are often called “silent killers”, but there is nothing silent about their impact. They remain one of the hardest public health battles to win. According to the World Health Organisation (WHO), they cause 43 million deaths worldwide and account for 75% of non-pandemi

From Potential to Practice: AI for Diabetes and Hypertension Prevention in Thailand

Background & RationaleNon-communicable diseases (NCDs) are the leading cause of death worldwide, responsible for 43 million deaths annually and accounting for 75% of all non-pandemic-related mortality globally [1]. Cardiovascular disease, diabetes, cancer, and chronic respiratory conditions drive this burden, yet most health systems remain orie

Target product profiles: opportunities and implications for health innovation development–a scoping review

Highlights By reviewing 120 Target Product Profiles (TPPs), this study identified key aspects of TPP development processes, stakeholder involvement, common themes, major limitations, and priorities for follow-up research. Health technologies were classified into five categories, and the pr

Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le

Early Health Technology Assessment of Non-sputum-based Assays for Screening and Treatment Monitoring in a prospective cohort of pulmonary tuberculosis

Tuberculosis is caused by bacterium called Mycobacterium tuberculosis. It is a significant problem in Thailand as seen that in 2021 Thailand is in the World Health Organization’s list of 30 high-burden countries for tuberculosis. One of the problems about tuberculosis is inaccurate diagnosis due to insufficient sensitivity and specificity of prim

Review of Literature and Information to Support and Pilot testing the Process for Integrating Thai Innovation into Thailand’s Universal Health Coverage System: A Case Study of Advance Wound Dressing from the Thai Innovation List

The development of health and medical innovation is a key national strategy for Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a high-value medical and wellness hub while reducing dependence on imported medical technologies. The Thai Innovation List was established to promote the commerc

A scoping review of modelling in target product profile development for medical innovation

Background Target Product Profiles (TPPs) serve as strategic tools for planning medical innovation development, facilitating communication with regulators, and developing market access strategies. Modelling can assist TPPs development and provide guidance on defining attributes. This scoping review
10 / Page